688098 Stock Overview
Engages in the research, development, production, and sale of veterinary biological products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Shanghai Shen Lian Biomedical Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.24 |
| 52 Week High | CN¥8.13 |
| 52 Week Low | CN¥3.63 |
| Beta | 0.69 |
| 11 Month Change | 6.29% |
| 3 Month Change | 38.62% |
| 1 Year Change | -34.50% |
| 33 Year Change | -52.45% |
| 5 Year Change | -67.00% |
| Change since IPO | -85.76% |
Recent News & Updates
Shareholder Returns
| 688098 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.3% | -1.5% | -2.1% |
| 1Y | -34.5% | -9.4% | 2.8% |
Return vs Industry: 688098 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 688098 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 688098 volatility | |
|---|---|
| 688098 Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688098 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688098's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 389 | Xu Gao | www.slbio.com.cn |
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Shanghai Shen Lian Biomedical Corporation Fundamentals Summary
| 688098 fundamental statistics | |
|---|---|
| Market cap | CN¥2.15b |
| Earnings (TTM) | -CN¥19.73m |
| Revenue (TTM) | CN¥310.36m |
6.9x
P/S Ratio-109.1x
P/E RatioIs 688098 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688098 income statement (TTM) | |
|---|---|
| Revenue | CN¥310.36m |
| Cost of Revenue | CN¥117.65m |
| Gross Profit | CN¥192.71m |
| Other Expenses | CN¥212.44m |
| Earnings | -CN¥19.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.048 |
| Gross Margin | 62.09% |
| Net Profit Margin | -6.36% |
| Debt/Equity Ratio | 0% |
How did 688098 perform over the long term?
See historical performance and comparison